Forterre Gael 4

What Happened

• Forterre Gael, Chief Commercial Officer of VolitionRx (VNRX), had 5,251 shares of common stock retained/cancelled by the company on March 17, 2026 to satisfy tax withholding related to the settlement of 12,700 restricted stock units (RSUs). The report lists the shares at $0.19 each, an aggregate value of about $998.
• This was a tax-withholding/cancellation transaction (Form 4 code F), not an open-market sale by the reporting person.

Key Details

• Transaction date and price: 2026-03-17; 5,251 shares at $0.19 per share (aggregate ~$998).
• Reason: Shares were retained by VolitionRx to satisfy withholding on 12,700 RSUs upon settlement (footnote F1). No shares were sold by the reporting person or by VolitionRx in a market transaction.
• Managed shares note: Some shares are managed by Armorica Partners, LLC; Mr. Forterre is MD and sole shareholder of Armorica Partners and disclaims beneficial ownership except to the extent of his pecuniary interest (footnote F2).
• Shares owned after transaction: Not specified in the provided excerpt.
• Filing timeliness: Report filed 2026-03-19 for a 2026-03-17 transaction — appears timely (not marked late).

Context

• This is a routine tax-withholding action on RSU settlement (commonly called a “share surrender” or cashless withholding) and should not be interpreted as an open-market sale indicating sentiment. It reduces the insider’s outstanding shares only to cover taxes rather than being a liquidity-driven sale.